Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Anthony A. Rayner"'
Publikováno v:
Cytolytic Lymphocytes and Complement: Effectors of the Immune System ISBN: 9781351071291
In vitro culture of lymphocytes in interleukin-2 (IL-2) results in the generation of cytotoxic cells that lyse a broad spectrum of solid tumors, as well as hematopoietic cell tumors, without deliberate immunization. Peripheral blood is the source for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::984c637fee68a56446ecd6c3e3334a08
https://doi.org/10.1201/9781351071291-14
https://doi.org/10.1201/9781351071291-14
Publikováno v:
China Agricultural Economic Review. 4:281-299
PurposeThe purpose of this paper is to develop a theoretical model of price transmission from the farm to the retail sector, allowing not only for an interaction between oligopoly power, oligopsony power and non‐constant returns to scale in industr
Publikováno v:
Journal of International Development. 17:479-494
Various studies have investigated trends in commodity prices in the context of the Prebisch Singer Hypothesis. This paper applies new evidence on significance tests for trends in differenced and correlated stationary processes, to individual price se
Publikováno v:
Journal of International Development. 11:893-910
Recent policy reform in LDCs has centred on liberalizing markets and removing state intervention. This is of great importance for exporters in these nations as they are becoming exposed to greater price risk. Given the prominent role played by primar
Publikováno v:
Weltwirtschaftliches Archiv. 129:345-366
Intra-Industry Trade and Limited Producer Horizons: An Empirical Investigation. — Following three decades of growing integration, intra-European trade has expanded significantly. Much of the growth has been in intra-industry trade (ITT). ITT appear
Habtu Weldegebriel, University of Warwick\ud Abstract\ud The potential existence of buyer power in U.K. food retailing has attracted the scrutiny of the U.K.'s anti-trust authorities, culminating in the second of two comprehensive regulatory inquirie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe8d46c7f2dbc0a8c1fa22495fd4a4c4
http://wrap.warwick.ac.uk/886/1/WRAP_Weldegebriel_Buyer_power.pdf
http://wrap.warwick.ac.uk/886/1/WRAP_Weldegebriel_Buyer_power.pdf
Autor:
Edith A. Perez, Judith Luce, Anthony A. Rayner, Albert B. Deisseroth, Frank H. Valone, Carolyn Paradise, David R. Gandara, Frederick R. Aronson
Publikováno v:
Journal of Immunotherapy. 10:207-213
The feasibility and efficacy of treating patients with locally recurrent or metastatic non-small cell lung cancer (NSCLC) or head/neck cancer with interleukin-2 (IL-2), cisplatin, and 5-fluorouracil (5-FU) was tested. Treatment was given every 28 day
Autor:
D. A. Van Echo, Peter H. Wiernik, James H. Doroshow, K. Margolin, M Sznol, Frederick R. Aronson, David Parkinson, Anthony A. Rayner, Janice P. Dutcher, Jeff Abrams
Publikováno v:
Journal of Clinical Oncology. 8:1650-1656
Forty-seven patients with metastatic malignant melanoma were treated with two 5-day cycles of 100,000 U/kg recombinant interleukin-2 (IL-2) intravenously (IV) every 4 hours separated by 1 week. This dose and schedule of IL-2 were identical to those u
Autor:
Rasim Gucalp, Mario A. Eisenberger, Michael J. Hawkins, Michael B. Atkins, David R. Parkinson, Jeffrey S. Abrams, Anthony A. Rayner, Peter H. Wiernik, Frederick R. Aronson
Publikováno v:
JNCI Journal of the National Cancer Institute. 82:1202-1206
Sixteen patients with metastatic renal cell carcinoma were treated with high-dose bolus recombinant interleukin-2 (rIL-2) alone at a dose and schedule identical to those that produced a 35% response rate among 72 patients in a trial reported by the S
Autor:
M Sznol, Geoffrey R. Weiss, Michael B. Atkins, Elizabeth Paietta, Anthony A. Rayner, Ellen R. Gaynor, Richard I. Fisher, David Parkinson, Frederick R. Aronson, David H. Boldt, Michael J. Hawkins, Janice P. Dutcher, James H. Doroshow, Kim Margolin
Publikováno v:
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy. 15(1)
Patients (n = 22) with metastatic or unresectable colorectal carcinoma were treated with interleukin (IL)-2 and lymphokine-activated killer (LAK) cells in a phase II study conducted by the IL-2/LAK Working Group (ILWG). Eligibility criteria for the s